Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
暂无分享,去创建一个
Ashley P Jones | P. Williamson | A. Dick | D. Hughes | P. Woo | C. Edelsten | A. Ramanan | D. Benton | S. Compeyrot-Lacassagne | B. Hardwick | H. Hickey | M. Beresford | A. McKay | A. Dick | P. R. Williamson | Ashley P. Jones
[1] A. Dick,et al. Uveitis associated with juvenile idiopathic arthritis , 2015, Nature Reviews Rheumatology.
[2] Gareth T. Jones,et al. Current Evidence of Anti–Tumor Necrosis Factor α Treatment Efficacy in Childhood Chronic Uveitis: A Systematic Review and Meta‐Analysis Approach of Individual Drugs , 2014, Arthritis care & research.
[3] R. V. Van Gelder,et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. , 2014, Ophthalmology.
[4] Ashley P Jones,et al. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial) , 2014, Trials.
[5] M. Cordero-Coma,et al. Systematic Review of Anti-Tumor Necrosis Factor-alpha Therapy for Treatment of Immune-mediated Uveitis , 2013, Ocular immunology and inflammation.
[6] A. Dick,et al. Concise Report , 2022 .
[7] Alberto Martini,et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.
[8] A. Martini,et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. , 2008, Arthritis and rheumatism.
[9] K. Aalto,et al. Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. , 2007, Rheumatology.
[10] A. Dick,et al. Biologics in the treatment of uveitis , 2007, Current opinion in ophthalmology.
[11] C. Foster,et al. Biological response modifier therapy for refractory childhood uveitis , 2007, British Journal of Ophthalmology.
[12] R. Saurenmann,et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. , 2007, The Journal of rheumatology.
[13] N. Wulffraat,et al. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study. , 2007, Arthritis and rheumatism.
[14] R. Saurenmann,et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. , 2007, Arthritis and rheumatism.
[15] A. Dick,et al. Use of infliximab in juvenile onset rheumatological disease-associated refractory uveitis: efficacy in joint and ocular disease , 2006, Annals of the rheumatic diseases.
[16] Stuart J Pocock,et al. Current controversies in data monitoring for clinical trials , 2006, Clinical trials.
[17] M. Zierhut,et al. Adalimumab in the therapy of uveitis in childhood , 2006, British Journal of Ophthalmology.
[18] R. Saurenmann,et al. Tumour necrosis factor α inhibitors in the treatment of childhood uveitis , 2006 .
[19] Douglas A Jabs,et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.
[20] E. Giannini,et al. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.
[21] M. Suarez‐Almazor,et al. International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .
[22] N. Wulffraat,et al. Visual loss in uveitis of childhood , 2003, The British journal of ophthalmology.
[23] H. Kautiainen,et al. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. , 2001, Ophthalmology.
[24] S. Sawhney,et al. The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). , 2001, Clinical and experimental rheumatology.
[25] D. Felson,et al. Preliminary definition of improvement in juvenile arthritis. , 1997, Arthritis and rheumatism.
[26] P. Lichter,et al. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. , 1987, Ophthalmology.
[27] B. Thiers. Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis , 2009 .
[28] R. Saurenmann,et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. , 2006, Rheumatology.
[29] Andrew D. Dick,et al. The standardization of uveitis nomenclature (SUN) working group; standardization of uveitis nomenclature for reporting clinical data: Results of the first international workshop , 2005 .
[30] J. Forrester,et al. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). , 2004, Progress in retinal and eye research.